New safety assessments of epilepsy medication are initiated because a Nordic research study concludes that epilepsy medication during pregnancy can lead to autism and intellectual disability in children.
Two ongoing research studies funded by NordForsk are providing important new knowledge about COVID-19 related to pregnancy and mental health. The director of NordForsk emphasises how the Nordic Region is leading the way in research on health data.
A unique multi-country database network with data from healthcare registers in Denmark, Norway, Sweden and Scotland with the purpose of conducting epidemiological studies on Covid-19.
The goal of this project is to, for the first time, create a joint Nordic long-term academic collaboration on pandemic preparedness using advanced mathematical modelling and systematically collected health data from a broad range of sources.
Project investigating the question of whether pregnant women ar more likely to contract COVID-19, and at a higher risk of severe disease, complications and hospitalizations than non-pregnant women of reproductive age.
Personalised medicine is an important priority area for the Nordic co-operation in medical research. Nordic universities have now joined forces to set up a massive open online course (MOOC) targeting personalised medicine where medical experts from the Nordic countries have contributed.